Logo image of CCAP

CRESCENT CAPITAL BDC INC (CCAP) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:CCAP - US2256551092 - Common Stock

13.96 USD
+0.13 (+0.94%)
Last: 11/24/2025, 8:00:02 PM
13.96 USD
0 (0%)
After Hours: 11/24/2025, 8:00:02 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to CCAP. CCAP was compared to 237 industry peers in the Capital Markets industry. There are concerns on the financial health of CCAP while its profitability can be described as average. CCAP has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year CCAP was profitable.
In the past year CCAP had a positive cash flow from operations.
CCAP had positive earnings in each of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: CCAP reported negative operating cash flow in multiple years.
CCAP Yearly Net Income VS EBIT VS OCF VS FCFCCAP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M -150M -200M

1.2 Ratios

Looking at the Return On Assets, with a value of 2.67%, CCAP is in line with its industry, outperforming 51.05% of the companies in the same industry.
CCAP has a Return On Equity (6.10%) which is comparable to the rest of the industry.
Looking at the Return On Invested Capital, with a value of 3.87%, CCAP is in line with its industry, outperforming 54.85% of the companies in the same industry.
Industry RankSector Rank
ROA 2.67%
ROE 6.1%
ROIC 3.87%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CCAP Yearly ROA, ROE, ROICCCAP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10

1.3 Margins

CCAP's Profit Margin of 24.12% is fine compared to the rest of the industry. CCAP outperforms 60.76% of its industry peers.
CCAP's Profit Margin has declined in the last couple of years.
With a decent Operating Margin value of 43.23%, CCAP is doing good in the industry, outperforming 78.90% of the companies in the same industry.
CCAP's Operating Margin has declined in the last couple of years.
CCAP has a Gross Margin (45.26%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of CCAP has declined.
Industry RankSector Rank
OM 43.23%
PM (TTM) 24.12%
GM 45.26%
OM growth 3Y-4.73%
OM growth 5Y-5.04%
PM growth 3Y-25.14%
PM growth 5Y-7.39%
GM growth 3Y-5.55%
GM growth 5Y-5.93%
CCAP Yearly Profit, Operating, Gross MarginsCCAP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

1

2. Health

2.1 Basic Checks

There is no outstanding debt for CCAP. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CCAP Yearly Shares OutstandingCCAP Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M
CCAP Yearly Total Debt VS Total AssetsCCAP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B

2.2 Solvency

Based on the Altman-Z score of 0.39, we must say that CCAP is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 0.39, CCAP is not doing good in the industry: 65.40% of the companies in the same industry are doing better.
The Debt to FCF ratio of CCAP is 13.58, which is on the high side as it means it would take CCAP, 13.58 years of fcf income to pay off all of its debts.
CCAP has a Debt to FCF ratio (13.58) which is in line with its industry peers.
A Debt/Equity ratio of 1.22 is on the high side and indicates that CCAP has dependencies on debt financing.
The Debt to Equity ratio of CCAP (1.22) is worse than 61.18% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.22
Debt/FCF 13.58
Altman-Z 0.39
ROIC/WACCN/A
WACCN/A
CCAP Yearly LT Debt VS Equity VS FCFCCAP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M 800M

2.3 Liquidity

CCAP has a Current Ratio of 0.61. This is a bad value and indicates that CCAP is not financially healthy enough and could expect problems in meeting its short term obligations.
CCAP has a worse Current ratio (0.61) than 71.31% of its industry peers.
A Quick Ratio of 0.61 indicates that CCAP may have some problems paying its short term obligations.
CCAP has a Quick ratio of 0.61. This is in the lower half of the industry: CCAP underperforms 71.31% of its industry peers.
Industry RankSector Rank
Current Ratio 0.61
Quick Ratio 0.61
CCAP Yearly Current Assets VS Current LiabilitesCCAP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M

3

3. Growth

3.1 Past

CCAP shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -26.15%.
Measured over the past 5 years, CCAP shows a small growth in Earnings Per Share. The EPS has been growing by 7.26% on average per year.
The Revenue has been growing slightly by 7.18% in the past year.
Measured over the past years, CCAP shows a very strong growth in Revenue. The Revenue has been growing by 29.83% on average per year.
EPS 1Y (TTM)-26.15%
EPS 3Y10.16%
EPS 5Y7.26%
EPS Q2Q%-28.12%
Revenue 1Y (TTM)7.18%
Revenue growth 3Y28.05%
Revenue growth 5Y29.83%
Sales Q2Q%-19.91%

3.2 Future

CCAP is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -16.69% yearly.
CCAP is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -9.44% yearly.
EPS Next Y-26.21%
EPS Next 2Y-17.42%
EPS Next 3Y-16.69%
EPS Next 5YN/A
Revenue Next Year-14.83%
Revenue Next 2Y-10.04%
Revenue Next 3Y-9.44%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CCAP Yearly Revenue VS EstimatesCCAP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M 200M
CCAP Yearly EPS VS EstimatesCCAP Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5 2 2.5

6

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 7.27 indicates a rather cheap valuation of CCAP.
Compared to the rest of the industry, the Price/Earnings ratio of CCAP indicates a rather cheap valuation: CCAP is cheaper than 85.65% of the companies listed in the same industry.
CCAP is valuated cheaply when we compare the Price/Earnings ratio to 25.65, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 8.06, the valuation of CCAP can be described as reasonable.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CCAP indicates a rather cheap valuation: CCAP is cheaper than 83.12% of the companies listed in the same industry.
CCAP's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 34.45.
Industry RankSector Rank
PE 7.27
Fwd PE 8.06
CCAP Price Earnings VS Forward Price EarningsCCAP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

CCAP's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. CCAP is cheaper than 76.79% of the companies in the same industry.
Industry RankSector Rank
P/FCF 7.92
EV/EBITDA N/A
CCAP Per share dataCCAP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

CCAP's earnings are expected to decrease with -16.69% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)1
EPS Next 2Y-17.42%
EPS Next 3Y-16.69%

5

5. Dividend

5.1 Amount

CCAP has a Yearly Dividend Yield of 12.54%, which is a nice return.
Compared to an average industry Dividend Yield of 8.60, CCAP pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.41, CCAP pays a better dividend.
Industry RankSector Rank
Dividend Yield 12.54%

5.2 History

CCAP has been paying a dividend for over 5 years, so it has already some track record.
CCAP has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years4
Div Non Decr Years4
CCAP Yearly Dividends per shareCCAP Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2

5.3 Sustainability

CCAP pays out 162.76% of its income as dividend. This is not a sustainable payout ratio.
DP162.76%
EPS Next 2Y-17.42%
EPS Next 3Y-16.69%
CCAP Yearly Income VS Free CF VS DividendCCAP Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M -150M -200M
CCAP Dividend Payout.CCAP Dividend Payout, showing the Payout Ratio.CCAP Dividend Payout.PayoutRetained Earnings

CRESCENT CAPITAL BDC INC

NASDAQ:CCAP (11/24/2025, 8:00:02 PM)

After market: 13.96 0 (0%)

13.96

+0.13 (+0.94%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)11-12 2025-11-12/amc
Earnings (Next)02-17 2026-02-17/amc
Inst Owners52.29%
Inst Owner Change4.94%
Ins Owners1.15%
Ins Owner Change0.07%
Market Cap517.36M
Revenue(TTM)197.36M
Net Income(TTM)44.18M
Analysts84.62
Price Target16.03 (14.83%)
Short Float %0.85%
Short Ratio1.27
Dividend
Industry RankSector Rank
Dividend Yield 12.54%
Yearly Dividend1.9
Dividend Growth(5Y)N/A
DP162.76%
Div Incr Years4
Div Non Decr Years4
Ex-Date12-31 2025-12-31 (0.42)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-9.71%
Min EPS beat(2)-15.91%
Max EPS beat(2)-3.5%
EPS beat(4)1
Avg EPS beat(4)-3.56%
Min EPS beat(4)-15.91%
Max EPS beat(4)9.46%
EPS beat(8)4
Avg EPS beat(8)2.4%
EPS beat(12)7
Avg EPS beat(12)2.79%
EPS beat(16)10
Avg EPS beat(16)3.02%
Revenue beat(2)0
Avg Revenue beat(2)-4.62%
Min Revenue beat(2)-8.38%
Max Revenue beat(2)-0.86%
Revenue beat(4)1
Avg Revenue beat(4)-2.26%
Min Revenue beat(4)-8.38%
Max Revenue beat(4)3.96%
Revenue beat(8)5
Avg Revenue beat(8)-0.53%
Revenue beat(12)7
Avg Revenue beat(12)0.41%
Revenue beat(16)8
Avg Revenue beat(16)0.69%
PT rev (1m)-7.56%
PT rev (3m)-8.01%
EPS NQ rev (1m)0%
EPS NQ rev (3m)2.16%
EPS NY rev (1m)0%
EPS NY rev (3m)1.27%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.25%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.22%
Valuation
Industry RankSector Rank
PE 7.27
Fwd PE 8.06
P/S 2.82
P/FCF 7.92
P/OCF 7.92
P/B 0.71
P/tB 0.71
EV/EBITDA N/A
EPS(TTM)1.92
EY13.75%
EPS(NY)1.73
Fwd EY12.41%
FCF(TTM)1.76
FCFY12.63%
OCF(TTM)1.76
OCFY12.63%
SpS4.94
BVpS19.56
TBVpS19.56
PEG (NY)N/A
PEG (5Y)1
Graham Number29.07
Profitability
Industry RankSector Rank
ROA 2.67%
ROE 6.1%
ROCE 4.9%
ROIC 3.87%
ROICexc 3.9%
ROICexgc 3.9%
OM 43.23%
PM (TTM) 24.12%
GM 45.26%
FCFM 35.68%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-4.73%
OM growth 5Y-5.04%
PM growth 3Y-25.14%
PM growth 5Y-7.39%
GM growth 3Y-5.55%
GM growth 5Y-5.93%
F-Score4
Asset Turnover0.11
Health
Industry RankSector Rank
Debt/Equity 1.22
Debt/FCF 13.58
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 1.35
Cash Conversion N/A
Profit Quality 147.94%
Current Ratio 0.61
Quick Ratio 0.61
Altman-Z 0.39
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)123.47%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-26.15%
EPS 3Y10.16%
EPS 5Y7.26%
EPS Q2Q%-28.12%
EPS Next Y-26.21%
EPS Next 2Y-17.42%
EPS Next 3Y-16.69%
EPS Next 5YN/A
Revenue 1Y (TTM)7.18%
Revenue growth 3Y28.05%
Revenue growth 5Y29.83%
Sales Q2Q%-19.91%
Revenue Next Year-14.83%
Revenue Next 2Y-10.04%
Revenue Next 3Y-9.44%
Revenue Next 5YN/A
EBIT growth 1Y-13.05%
EBIT growth 3Y21.99%
EBIT growth 5Y23.29%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y8.71%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y8.71%
OCF growth 3YN/A
OCF growth 5YN/A

CRESCENT CAPITAL BDC INC / CCAP FAQ

What is the ChartMill fundamental rating of CRESCENT CAPITAL BDC INC (CCAP) stock?

ChartMill assigns a fundamental rating of 3 / 10 to CCAP.


What is the valuation status of CRESCENT CAPITAL BDC INC (CCAP) stock?

ChartMill assigns a valuation rating of 6 / 10 to CRESCENT CAPITAL BDC INC (CCAP). This can be considered as Fairly Valued.


What is the profitability of CCAP stock?

CRESCENT CAPITAL BDC INC (CCAP) has a profitability rating of 4 / 10.


Can you provide the financial health for CCAP stock?

The financial health rating of CRESCENT CAPITAL BDC INC (CCAP) is 1 / 10.


Can you provide the dividend sustainability for CCAP stock?

The dividend rating of CRESCENT CAPITAL BDC INC (CCAP) is 5 / 10 and the dividend payout ratio is 162.76%.